Zimmer Biomet Holdings Stock Performance

ZBH Stock  USD 89.91  0.66  0.73%   
The firm maintains a market beta of 0.5, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Zimmer Biomet's returns are expected to increase less than the market. However, during the bear market, the loss of holding Zimmer Biomet is expected to be smaller as well. At this point, Zimmer Biomet Holdings has a negative expected return of -0.17%. Please make sure to check out Zimmer Biomet's treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Zimmer Biomet Holdings performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Zimmer Biomet Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's fundamental drivers remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more

Actual Historical Performance (%)

One Day Return
(0.73)
Five Day Return
2.22
Year To Date Return
(13.93)
Ten Year Return
(12.23)
All Time Return
211.43
Forward Dividend Yield
0.0107
Payout Ratio
0.1187
Last Split Factor
103:100
Forward Dividend Rate
0.96
Dividend Date
2025-10-31
1
Disposition of 1281 shares by Paul Stellato of Zimmer Biomet subject to Rule 16b-3
08/29/2025
2
Zimmer Biomet Holdings Inc. 2025 Product Pipeline Analysis by Equipment Type, Indication, Development Stage, and Trial Status
10/21/2025
3
Zimmer Biomet wins FDA breakthrough nod for first iodine-treated hip replacement system
10/28/2025
 
Zimmer Biomet dividend paid on 31st of October 2025
10/31/2025
4
Zimmer Biomet Earnings What To Look For From ZBH
11/04/2025
5
Zimmer Biomet price target lowered by 8 at Baird, heres why ZBH
11/06/2025
6
The SPAIN-US CHAMBER of COMMERCE in Florida Celebrates Its 45th Anniversary Gala With Over 420 Business Leaders and Renowned Figures in Miami
11/07/2025
7
Zimmer Biomet accused of filing a through the looking glass suit
11/10/2025
8
2 SP 500 Stocks Worth Your Attention and 1 We Turn Down
11/11/2025
9
There May Be Reason For Hope In Zimmer Biomet Holdings Disappointing Earnings
11/12/2025
10
Why Zimmer Biomet is a Top Value Stock for the Long-Term
11/14/2025
Begin Period Cash Flow415.8 M
Total Cashflows From Investing Activities-888.1 M

Zimmer Biomet Relative Risk vs. Return Landscape

If you would invest  10,231  in Zimmer Biomet Holdings on August 18, 2025 and sell it today you would lose (1,240) from holding Zimmer Biomet Holdings or give up 12.12% of portfolio value over 90 days. Zimmer Biomet Holdings is generating negative expected returns assuming volatility of 2.3009% on return distribution over 90 days investment horizon. In other words, 20% of stocks are less volatile than Zimmer, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Zimmer Biomet is expected to under-perform the market. In addition to that, the company is 3.53 times more volatile than its market benchmark. It trades about -0.07 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of volatility.

Zimmer Biomet Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Zimmer Biomet's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zimmer Biomet Holdings, and traders can use it to determine the average amount a Zimmer Biomet's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0741

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsZBH

Estimated Market Risk

 2.3
  actual daily
20
80% of assets are more volatile

Expected Return

 -0.17
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.07
  actual daily
0
Most of other assets perform better
Based on monthly moving average Zimmer Biomet is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zimmer Biomet by adding Zimmer Biomet to a well-diversified portfolio.

Zimmer Biomet Fundamentals Growth

Zimmer Stock prices reflect investors' perceptions of the future prospects and financial health of Zimmer Biomet, and Zimmer Biomet fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zimmer Stock performance.

About Zimmer Biomet Performance

By evaluating Zimmer Biomet's fundamental ratios, stakeholders can gain valuable insights into Zimmer Biomet's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zimmer Biomet has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zimmer Biomet has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 372.35  265.71 
Return On Tangible Assets 0.12  0.17 
Return On Capital Employed 0.07  0.06 
Return On Assets 0.04  0.04 
Return On Equity 0.07  0.07 

Things to note about Zimmer Biomet Holdings performance evaluation

Checking the ongoing alerts about Zimmer Biomet for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zimmer Biomet Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Zimmer Biomet generated a negative expected return over the last 90 days
Zimmer Biomet has a strong financial position based on the latest SEC filings
Over 100.0% of the company outstanding shares are owned by institutional investors
On 31st of October 2025 Zimmer Biomet paid $ 0.24 per share dividend to its current shareholders
Latest headline from simplywall.st: Can Surgery Partners Updated Guidance Change the Conversation on Profitability
Evaluating Zimmer Biomet's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Zimmer Biomet's stock performance include:
  • Analyzing Zimmer Biomet's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zimmer Biomet's stock is overvalued or undervalued compared to its peers.
  • Examining Zimmer Biomet's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Zimmer Biomet's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zimmer Biomet's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Zimmer Biomet's stock. These opinions can provide insight into Zimmer Biomet's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Zimmer Biomet's stock performance is not an exact science, and many factors can impact Zimmer Biomet's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Zimmer Stock analysis

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios